# FDA Inspection 1319642 - Linde Inc. - May 28, 2026

Source: https://www.keypedia.com/records/fda_inspections/linde-inc/55b9a3ed-7307-48a1-a6d3-59afde28e6d0
Source feed: FDA_Inspections

> FDA Inspection 1319642 for Linde Inc. on May 28, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1319642
- Company Name: Linde Inc.
- Inspection Date: 2026-05-28
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 855169 - 2013-11-14](https://www.keypedia.com/records/fda_inspections/linde-inc/71420ebd-84ad-4f5a-bded-00156b3ab490)

Company: https://www.keypedia.com/companies/linde-inc/5d3cc304-5931-4cc5-bb47-eef2a089bcd5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c